Vigabatrin Quantitative, Serum or Plasma
Also known as: VIGABAT
Use
This test is used to optimize drug therapy and monitor patient adherence to vigabatrin, an antiepileptic medication. It provides quantitative measurement of vigabatrin levels in serum or plasma, which is critical for therapeutic drug monitoring. Monitoring drug levels helps ensure efficacy of the drug, prevent toxicity, and maintain appropriate dosing. Proper monitoring of vigabatrin levels is especially important given its potential side effects and the necessity to adjust dosage for individual patient needs.
Special Instructions
Not provided.
Limitations
The test is conducted by NMS Labs and its performance characteristics were determined by them. It has not been cleared or approved by the US Food and Drug Administration. Quantitative results might vary depending on the dose and the patient's condition. Certain substances or conditions may interfere with the assay results, thus affecting the accuracy of drug concentration measurements.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
Vigabatrin
Analyte
LOINC Codes
- 30042-6 - Vigabatrin SerPl-mCnc
Result Turnaround Time
8-11 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Container
ARUP standard transport tube
Collection Instructions
Separate from cells ASAP or within 2 hours of collection.
Storage Instructions
Refrigerated. Also acceptable at room temperature or frozen.
Causes for Rejection
Gel separator tubes.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 month |
| Refrigerated | 1 month |
| Frozen | 2 years |
Other tests from different labs that may be relevant